Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 10 | $1,048,338 |
Sells | 17 | $6,122,651 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
25 Jun 2024 16:39 | BCRX | BIOCRYST PHARMACEUTICALS INC | MCKEE AMY E | Director | 24 Jun 2024 | Sale | 8,600 | 6.32 | 54,352 | D |
17 Jun 2024 16:31 | BCRX | BIOCRYST PHARMACEUTICALS INC | SANDERS MACHELLE | Director | 17 Jun 2024 | Sale | 4,689 | 6 | 28,134 | D |
14 Jun 2024 16:25 | BCRX | BIOCRYST PHARMACEUTICALS INC | HEGGIE THERESA | Director | 14 Jun 2024 | Sale | 6,698 | 6.11 | 40,925 | D |
31 May 2024 16:25 | BCRX | BIOCRYST PHARMACEUTICALS INC | LEVIN ALAN G | Director | 30 May 2024 | Purchase | 7,861 | 6.36 | 49,996 | D |
29 May 2024 16:16 | BCRX | BIOCRYST PHARMACEUTICALS INC | ASELAGE STEVE | Director | 24 May 2024 | Purchase | 2,500 | 6.4 | 16,000 | I |
22 May 2024 07:21 | BCRX | BIOCRYST PHARMACEUTICALS INC | MILANO VINCENT | Director | 20 May 2024 | Purchase | 15,000 | 6.25 | 93,750 | D |
22 May 2024 07:24 | BCRX | BIOCRYST PHARMACEUTICALS INC | HUTSON NANCY J | Director | 20 May 2024 | Purchase | 5,000 | 6.38 | 31,900 | D |
15 May 2024 07:19 | BCRX | BIOCRYST PHARMACEUTICALS INC | DOYLE ANTHONY | Chief Financial Officer | 14 May 2024 | Purchase | 36,300 | 5.57 | 202,191 | D |
15 May 2024 07:14 | BCRX | BIOCRYST PHARMACEUTICALS INC | GALSON STEVEN K | Director | 13 May 2024 | Purchase | 21,940 | 5.49 | 120,451 | D |
15 May 2024 07:11 | BCRX | BIOCRYST PHARMACEUTICALS INC | BARNES ALANE P | Chief Legal Officer | 13 May 2024 | Purchase | 5,000 | 5.53 | 27,650 | D |
15 May 2024 07:17 | BCRX | BIOCRYST PHARMACEUTICALS INC | THACKRAY HELEN M. | Chief R&D Officer | 14 May 2024 | Purchase | 30,000 | 5.86 | 175,800 | D |
15 May 2024 07:04 | BCRX | BIOCRYST PHARMACEUTICALS INC | GAYER CHARLES K | Chief Commercial Officer | 13 May 2024 | Purchase | 30,000 | 5.47 | 164,100 | D |
15 May 2024 07:08 | BCRX | BIOCRYST PHARMACEUTICALS INC | STONEHOUSE JON P | President & CEO | 13 May 2024 | Purchase | 30,000 | 5.55 | 166,500 | D |
05 Apr 2023 16:33 | BCRX | BIOCRYST PHARMACEUTICALS INC | THACKRAY HELEN M. | Chief R&D Officer | 03 Apr 2023 | Sale | 7,000 | 8.29 | 58,030 | D |
02 Feb 2023 17:20 | BCRX | BIOCRYST PHARMACEUTICALS INC | STONEHOUSE JON P | President & CEO | 01 Feb 2023 | Sale | 100,000 | 10.38 | 1,038,000 | D |
19 Dec 2022 17:09 | BCRX | BIOCRYST PHARMACEUTICALS INC | STONEHOUSE JON P | President & CEO | 15 Dec 2022 | Sale | 14,100 | 10.9 | 153,690 | D |
19 Dec 2022 16:55 | BCRX | BIOCRYST PHARMACEUTICALS INC | DOYLE ANTHONY | Chief Financial Officer | 15 Dec 2022 | Sale | 5,700 | 10.9 | 62,130 | D |
19 Dec 2022 16:58 | BCRX | BIOCRYST PHARMACEUTICALS INC | THACKRAY HELEN M. | Chief R&D Officer | 15 Dec 2022 | Sale | 3,125 | 10.89 | 34,031 | D |
19 Dec 2022 16:45 | BCRX | BIOCRYST PHARMACEUTICALS INC | JONES MICHAEL L | Exec. Director, Finance - PAO | 15 Dec 2022 | Sale | 445 | 10.9 | 4,850 | D |
19 Dec 2022 16:48 | BCRX | BIOCRYST PHARMACEUTICALS INC | GAYER CHARLES K | Chief Commercial Officer | 15 Dec 2022 | Sale | 6,100 | 10.9 | 66,490 | D |
19 Dec 2022 16:38 | BCRX | BIOCRYST PHARMACEUTICALS INC | BARNES ALANE P | Chief Legal Officer | 15 Dec 2022 | Sale | 4,175 | 10.88 | 45,424 | D |
02 Dec 2022 18:36 | BCRX | BIOCRYST PHARMACEUTICALS INC | JONES MICHAEL L | Exec. Director, Finance - PAO | 01 Dec 2022 | Sale | 8,600 | 13.01 | 111,886 | D |
02 Dec 2022 18:33 | BCRX | BIOCRYST PHARMACEUTICALS INC | STONEHOUSE JON P | President & CEO | 02 Dec 2022 | Sale | 82,656 | 12.8 | 1,057,997 | D |
02 Dec 2022 18:33 | BCRX | BIOCRYST PHARMACEUTICALS INC | STONEHOUSE JON P | President & CEO | 01 Dec 2022 | Sale | 214,917 | 13 | 2,793,921 | D |
16 Nov 2022 16:19 | BCRX | BIOCRYST PHARMACEUTICALS INC | BABU YARLAGADDA S | Chief Discovery Officer | 14 Nov 2022 | Sale | 31,515 | 13.88 | 437,428 | D |
15 Jun 2023 16:37 | BCRX | BIOCRYST PHARMACEUTICALS INC | SANDERS MACHELLE | Director | 15 Jun 2023 | Sale | 4,000 | 7.98 | 31,920 | D |
15 Jun 2023 16:33 | BCRX | BIOCRYST PHARMACEUTICALS INC | HUTSON NANCY J | Director | 14 Jun 2023 | Sale | 12,866 | 8.04 | 103,443 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)